Business Impact of COVID-19
First written in FY2020-Q3. 4 of 12 entries say "Restated". Latest entry: FY2024-Q1.
The whole theme swung hardest in 2020: 103 of 175 companies on the "Worse" side.
38 other companies' latest entry also says "Dropped".
- FY2024-Q1DroppedAnnual reportThe business and other risks section and the analysis of operating results for the quarter contained no direct reference to the business impact of the novel coronavirus infection, and stated that only the worsening situation in Ukraine would continue to be monitored.
- FY2023MitigatedAnnual report
「Regarding the impact of the novel coronavirus infection, the Company steadily implemented infection-control measures in recruitment, sales and employee follow-up systems, including the wider adoption of telework and interviews using web tools. In addition, the infection was downgraded to a Category 5 disease, and the direct impact on the Group's business activities is currently almost nonexistent.」
In addition to infection-control measures such as telework and web interviews, the downgrading of the infection to a Category 5 disease meant that the direct impact on business activities was considered to be almost nonexistent. - FY2023-Q2RestatedAnnual report
「The Company will continue to monitor the impact on its business of the spread of the novel coronavirus infection and the worsening situation in Ukraine.」
The impact of the novel coronavirus infection on business continues to be monitored together with the situation in Ukraine. - FY2023-Q1RestatedAnnual report
「The Company will continue to monitor the impact on its business of the spread of the novel coronavirus infection and the worsening situation in Ukraine.」
The impact of the spread of the infection on business continues to be identified as an area requiring monitoring. - FY2022MitigatedAnnual report
「Meanwhile, the Company steadily implemented infection-control measures in recruitment, sales and employee follow-up systems, including the wider adoption of telework and interviews using web tools. As the direct impact of the novel coronavirus infection on the Group's business activities had been reduced, there was currently almost no impact on business activities.」
The Company stated that infection-control measures such as telework and web interviews had reduced the direct impact of the infection on business activities to almost zero. However, future risks remained if customer activities or employees' economic activities were restricted. - FY2022-Q2WorsenedAnnual report
「The number of new novel coronavirus cases remained subdued after the state of emergency was lifted in May last year, and economic conditions gradually began to recover. However, the situation remained unpredictable, with infections spreading again from the end of last year, and the Company stated that it would continue to monitor the future impact.」
Based on the disclosures that infections had remained subdued and the economy had recovered, the situation changed after the end of the year to one in which infections were spreading again and the impact on business continued to be monitored. - FY2022-Q1RestatedAnnual report
「During the first quarter consolidated cumulative period, there were no new business or other risks, nor any significant changes to the business and other risks described in the securities report for the previous fiscal year. As of October 2021, the number of new COVID-19 cases was at a low level, but the Company stated that it would continue to monitor the impact should infections spread again.」
The Company stated that there were no new risks or significant changes concerning the novel coronavirus infection, while continuing to monitor the impact of a renewed spread even with new cases at low levels. - FY2021MitigatedAnnual report
「Meanwhile, the Group steadily implemented infection-control measures in recruitment, sales and employee follow-up systems, including the wider adoption of telework and interviews using web tools, and established a business operating structure comparable to that in normal times. As a result, the direct impact of the novel coronavirus infection on the Group's business activities has been reduced.」
Although lower demand and utilization rates caused by the infection remained risks, the Company stated that the direct impact on business activities had been reduced through telework, web interviews and other measures. - FY2021-Q2MaterialisedAnnual report
「Although revenue in the technology-related segment declined only slightly, the manufacturing-related and overseas segments recorded substantial revenue declines due to deteriorating market conditions caused by COVID-19.」
The continuing impact of the novel coronavirus was reflected in the quarterly results through substantial revenue declines in the manufacturing-related and overseas segments and persistently low utilization rates in the technology-related segment. - FY2021-Q1RestatedAnnual report
「During the first quarter of the consolidated cumulative period, there were no new business or other risks, nor any material changes to the business or other risks described in the annual securities report for the previous fiscal year. The impact on the business of the spread of the novel coronavirus disease (COVID-19) will continue to be closely monitored.」
The Company stated that it would continue to monitor the impact of the novel coronavirus infection on its business, and that there were no new risks or significant changes. - FY2020MaterialisedAnnual report
「A recovery in demand for semiconductor-related personnel, which had stagnated due to the US-China trade dispute and other factors, was also expected. However, the spread of the novel coronavirus infection during the fourth quarter consolidated accounting period restricted economic activity worldwide and dealt a severe blow to Japan's manufacturing industry.」
In the fourth quarter, the impact of the novel coronavirus infection materialized in the form of global restrictions on economic activity and a severe blow to Japan's manufacturing industry, leading to lower utilization rates, lower revenue and profit, and impairment of overseas goodwill. - FY2020-Q3First statedAnnual report
「However, with the global impact of COVID-19 (the novel coronavirus) becoming apparent not only on corporate activity but also on social activity, the period saw a gradual impact on the Group's businesses in Japan, as well as in China.」
The section on business and other risks stated that no new risks had arisen, while the analysis of operating results explicitly noted for the first time that the impact of COVID-19 on the Chinese and domestic businesses was becoming apparent. It also stated that this had affected impairment of goodwill in the UK business.